Navigation Links
Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain
Date:6/1/2009

Some reduction in mortality rates found, but experts say more follow-up needed

MONDAY, June 1 (HealthDay News) -- Patients checked for colon cancer with a procedure called flexible sigmoidoscopy showed no significant reduction in risk over seven years, but the screening did seem to lower the risk of dying from the disease, Norwegian researchers report.

There are several methods available for colon cancer screening including colonoscopy, which involves a look at the whole colon and the removal of any precancerous or cancerous polyps. In addition, there is flexible sigmoidoscopy, which uses a flexible endoscope to examine the large intestine only. There are also noninvasive tests such as fecal occult blood sampling and CT colonoscopy.

"Flexible sigmoidoscopy screening looks promising, but the effect on a population level appears less than expected and further follow-up is required," said lead researcher Dr. Geir Hoff, from the Cancer Registry of Norway in Oslo.

These are the first results from the trial, and it may be that seven years is too short a time to see the true effect of screening, Hoff said.

"The results suggest that flexible sigmoidoscopy screening may be a very efficient way of screening with an aim of reducing mortality and the risk of getting colorectal cancer, but the effect may be less than anticipated and certainly occurs later than expected in the follow-up period," Hoff added.

Until now, there have been results from randomized trials only for one colorectal cancer screening modality -- screening for blood in the stools, Hoff said. "Still, colonoscopy is recommended in several European countries and the U.S.," he added.

The report is published in the June 1 online edition of the BMJ, to coincide with the scheduled presentation of the findings Monday at the Digestive Diseases Week meeting in Chicago.

For the study, Hoff's team randomly assigned almost 56
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Not Worthy of Support? Democratic Leaders Continue to Ignore Americas Youth
2. Pricey Running Shoes Not Worth It: Study
3. Knights to Distribute $1 Million Worth of Wheelchairs for Veterans
4. Knights Distribute $1 Million Worth of Wheelchairs to Veterans
5. Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor
6. Dallas-Fort Worth Business Group on Health Releases Report on the State of Diabetes in Texas
7. Taxol with avastin produces noteworthy results
8. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
9. A Fort Worth Couple Sues Huguley Memorial Medical Center
10. Renaissance Health Publishing, LLC Warns the Public that ConsumerLab.com is Not Independent and Labels the CL Seal of Approval a Worthless, Paid-For Advertising Gimmick
11. Social Security Is Worth $225,000 for a Typical Retiree
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Emergo Group, ... in 26 countries in North and South America, Europe, ... responses from industry participants for its 2015 Medical Device ... order to identify upcoming business and market trends as ... , The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Kenmode Precision ... the firm as Director of Quality Assurance. He ... quality systems, processes and certifications for manufacturers in the ... posts of Corporate Quality Manager at Sonoco Products Company ... at NetCom, Inc., and Quality Assurance Manager for Prince ...
(Date:12/15/2014)... Metal drilling machines have ... This score indicates that neither buyers nor suppliers have ... have been raising the price of metal drilling machines ... rising demand,” according to IBISWorld business research analyst, Jeffrey ... During the past three years, high price driver volatility ...
Breaking Medicine News(10 mins):Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 3
... to excess days off, poor-quality output, study finds , , ... attention deficit hyperactivity disorder (ADHD) miss, on average, more ... to a new global reckoning of the problem. , ... worldwide have ADHD, according to survey data from the ...
... Neck, leg sites similar, but jugular should be choice for ... News) -- There,s little overall difference in infection risk if ... or an upper leg vein in critically ill patients, French ... is less likely to cause infection than the leg catheter. ...
... is not a phrase normally used to describe a ... Tel Aviv University, the chemical industry is a step ... from the School of Chemistry at Tel Aviv University ... certain steps of a complicated chain of chemical reactions ...
... With many Americans eagerly,awaiting some extra cash in their ... time to make an investment in your health. As ... Association and its,3,000 members urge you to invest your ... "What,s more important than investing in your health?" said ...
... Introduces EveryKid(TM), An Organic First For Children,s ... ... food,chemical-free nutrition is ideal to a child,s healthy growth and,development, parents ... of chemical vitamin,isolates. But today, New Chapter -- the leading producer ...
... explain why some nonsmokers contract the disease, study says , , ... increases the risk of lung cancer, even in nonsmokers, researchers ... alpha1-antitrypsin gene double someones risk of developing lung cancer, regardless ... explain why some nonsmokers develop the disease, said study author ...
Cached Medicine News:Health News:Adults With ADHD Lose 3 Weeks Worth of Work Annually 2Health News:Adults With ADHD Lose 3 Weeks Worth of Work Annually 3Health News:Dialysis Catheter Placement Makes Little Difference in Infection Risk 2Health News:1 small step for a lab science, 1 green leap for mankind 2Health News:Invest in Your Future With a Spa Visit Today 2Health News:Invest in Your Future With a Spa Visit Today 3Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 2Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 3Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3
(Date:12/17/2014)... 17, 2014 Revenue and earnings above ... research and development In the past 2013/14 fiscal ... two percent to EUR 4.287 billion (last year: EUR 4.190 ... percent to EUR 360 million. "Overall, 2013/14 was a successful ... Kaschke , President and CEO of Carl Zeiss AG. "Thanks ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... -- PCCA received the Autism Hope Alliance,s (AHA) ... seal for best practices in meeting needs in ... materials and goods that meet strict criteria and ... by autism often have unique physical or psychological ... in food and medicine – for instance casein, ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 4 NovaRx Corporation announced today the appointment of ... and Chief Operating Officer. Dr. Russell brings to ... discovery and a long history of success driving innovation ... experience leading entrepreneurial biotechnology companies developing pioneering new technologies. ...
... - Tasigna front-line data demonstrating potential in newly diagnosed patients with ... sessions at ASH , , - ... by significantly reducing toxic iron that can damage key organs , ... major independent breast cancer trial at SABCS to report on optimal ...
Cached Medicine Technology:NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22
Inquire...
QC HGB is an assayed quality control material for Hemocue analyzers. This control is a solution of stabilized human red cells and is available in 3 levels for monitoring analyzer performance at sever...
... a state of the art software package designed ... Optical Laboratory. Designed by a lens manufacturer with ... polycarbonate lenses, Optifacts is designed to help you ... not the way the software dictates., ,Designed specifically ...
VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
Medicine Products: